Plain-English translation of NCT07367100 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is one of the first times this treatment has been tested in people.
This trial is testing a new medical device called the Adaptive Tip Catheter (ATC) that doctors use during emergency stroke treatment. The catheter is designed to remove blood clots from arteries in the brain that are blocking blood flow during an acute ischemic stroke. Researchers want to see if this treatment is safe and effective when used as the first approach to restore blood flow to the brain.
When someone has an acute ischemic stroke, time is critical—every minute without blood flow to the brain matters. This trial exists to evaluate whether this new catheter design can safely and effectively remove clots and restore blood flow faster than existing methods.
You likely qualify if…
You likely don't qualify if…
If you are having an acute stroke and meet the criteria, your medical team will use the Adaptive Tip Catheter as the first treatment approach during your emergency procedure to remove the blood clot from your brain. After the procedure, you will be followed closely in the hospital and will have follow-up visits and assessments over the next 90 days to monitor your recovery and check for any side effects or complications.
AI-generated summary from trial data · Aug 7, 2026 · Not medical advice
Belgium
France